Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Updated DEX PS DDS Applicator in Macular Edema
NCT04976777Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2021
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in macular edema, sponsored by AbbVie Inc.. Started Oct 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT04976777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04976777.